Ilesto DX Enables Atrial Sensing, Smaller, Thinner Single-Lead ICD

Ilesto DX enables atrial sensing in a smaller, thinner single-lead ICD


October 1, 2013
cardioverter defibrillator cardiac resynchronization therapy biotronik ilesto DX

Biotronik’s Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices) now includes the Ilesto DX. The new platform allows for a 15 percent size reduction and 29 percent fewer components with no compromise in longevity or clinical features. 

It is the first defibrillator system equipped to provide full atrial diagnostic information with just one specialized defibrillator lead. These capabilities have already been cited in multiple case studies, and physicians are now considering the DX System as a solution to the limited capabilities of single chamber or the additional complications associated with dual chamber devices.

For conventional ICD systems, providing atrial diagnostic capabilities means placing two wires (leads) in the heart, which can increase the likelihood of complications. The second alternative, a typical single-chamber (single-lead) ICD, has no sensing capability in the atrium and is therefore less equipped to detect silent high atrial rates that may cause stroke and inappropriate shocks.

The U.S. Food and Drug Administration (FDA) approved the device in September 2013.

For more information: